Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-07-14 Labrucherie Gil M SVP & Chief Financial Officer Grant or award · Stock Option +87,500 87,500
2016-07-14 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award +26,000 32,735
2016-07-14 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +50,000 50,000
2016-07-14 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +22,000 22,000
2016-07-14 Gergel Ivan P. SVP & Chief Medical Officer Grant or award +15,000 16,521
2016-07-14 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +50,000 50,000
2016-07-14 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +12,500 12,500
2016-07-14 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award +10,500 11,521
2016-07-14 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +50,000 50,000
2016-07-14 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +8,750 8,750
2016-07-11 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +100,000 $4.65 $465K 106,809
2016-07-11 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −100,000 $15.09 $1.5M 6,809
2016-07-11 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −100,000 0
2016-07-01 CHESS ROBERT Director Exercise or conversion +5,000 $5.15 $26K 265,623
2016-07-01 CHESS ROBERT Director Sale −5,000 $14.10 $71K 260,623
2016-07-01 CHESS ROBERT Director Exercise or conversion · Stock Option −5,000 5,000
2016-06-01 Nicholson John SVP & Chief Operating Officer Grant or award · Stock Option +100,000 100,000
2016-06-01 Labrucherie Gil M SVP & Chief Financial Officer Grant or award · Stock Option +100,000 100,000
2016-06-01 CHESS ROBERT Director Exercise or conversion +5,000 $5.15 $26K 265,623
2016-06-01 CHESS ROBERT Director Sale −5,000 $15.50 $78K 260,623

Page 51 of 55 · 1,088 trades